Cobalt(II) complexes of Sparfloxacin (cas 111542-93-9): Characterization, structure, antimicrobial activity and interaction with DNA and albumins
-
Add time:09/07/2019 Source:sciencedirect.com
The cobalt(II) complexes with the quinolone sparfloxacin (Hsf) in the absence or presence of the nitrogen-donor heterocyclic ligands 2,2′-bipyridine (bipy), 1,10-phenanthroline (phen) or 2,2′-bipyridylamine (bipyam) were prepared and characterized physicochemically and spectroscopically. The crystal structures of complexes [Co(sf)2(bipy)]∙3MeOH∙2H2O and [Co(sf)2(phen)]∙4MeOH were determined by X–ray crystallography. The antimicrobial activity of the complexes was tested against four different microorganisms (Escherichia coli, Xanthomonas campestris, Staphylococcus aureus and Bacillus subtilis) and was found similar or higher than that of free Hsf. The binding of the complexes to calf-thymus DNA was monitored by UV-vis spectroscopy and DNA-viscosity measurements and indirectly by competitive studies with ethidium bromide; intercalation is suggested as the most possible interaction mode. Fluorescence emission spectroscopy was used to evaluate the interaction of the complexes with human or bovine serum albumin and the corresponding binding constants were determined.
We also recommend Trading Suppliers and Manufacturers of Sparfloxacin (cas 111542-93-9). Pls Click Website Link as below: cas 111542-93-9 suppliers
Prev:Determination of Sparfloxacin (cas 111542-93-9) with CdSe/CdS quantum dots as fluorescent probes
Next:Original ArticleSimple and sensitive determination of Sparfloxacin (cas 111542-93-9) in pharmaceuticals and biological samples by immunoassay) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original ArticleSimple and sensitive determination of Sparfloxacin (cas 111542-93-9) in pharmaceuticals and biological samples by immunoassay09/08/2019
- Determination of Sparfloxacin (cas 111542-93-9) with CdSe/CdS quantum dots as fluorescent probes09/06/2019
- Short communicationImpact of Sparfloxacin (cas 111542-93-9) on melanogenesis and antioxidant defense system in normal human melanocytes HEMa-LP – An in vitro study09/05/2019
- A novel Fe3O4/graphene oxide/citrus peel-derived bio-char based nanocomposite with enhanced adsorption affinity and sensitivity of ciprofloxacin and Sparfloxacin (cas 111542-93-9)09/04/2019
- Phosphine derivatives of Sparfloxacin (cas 111542-93-9) – Synthesis, structures and in vitro activity09/03/2019
- Combined experimental and theoretical studies on the diorganotin(IV) complexes of Sparfloxacin (cas 111542-93-9): Synthesis, spectroscopic and DFT studies, and biological activity09/02/2019
- Sparfloxacin (cas 111542-93-9)09/01/2019


